Skip to main content
Image coming soon

GEN0335 Mastering AI in Drug Discovery for Senior Leaders

$201.00
Adding to cart… The item has been added

The Executive Diagnostic and Governance Toolkit

Mastering AI in Drug Discovery for Senior Leaders

Score your own function red, amber or green, find out which part is weakest, and walk into the next budget round able to defend what you want to fix. Built for leaders reviewing decide whether to invest in AI-driven drug discovery platforms this year.

$199 one-time
30-day money-back guarantee Verified against latest insights, updated access provided within 24h

Each order is checked and updated against the latest insights before delivery. That is why access takes up to 24 hours rather than being instant.

What you walk out with
A scored, ranked picture of your own function, and a defensible answer to what to fix first.
1 You stop guessing where you stand.
You finish with a score, not an opinion: every part of your function rated red, amber or green, with the weakest ranked first. Evidence: a Quick Scan for the shape of it, then seven domain assessments of 30 scored questions each, 210 in all, rolled into one scorecard, plus a maturity radar and a current-versus-target gap analysis.
2 You can defend the decision.
You walk into the budget round with the gap named, the owner named and done defined, instead of a case built on instinct. Evidence: project charter, scope statement, RACI, requirements traceability and work breakdown structure, pre-filled in your domain's language.
3 The work actually moves.
The month after the decision is already built, so nothing stalls waiting for someone to design a form. Evidence: more than 60 project templates across all five PMBOK process groups, plus runbooks, SOPs, a KPI framework, audit checklists and a risk matrix. 55 to 65 files in total.
4 You use it the day it lands.
No blank templates to interpret. Every workbook opens with what it is, who uses it, when, how, a 1 to 5 scoring guide, what good looks like, and a worked example you delete and type over.
The Quick Scan is one sitting. You will know your weakest area before the day is out.
Nothing in it is generic project management: the build rejects any file that could belong to another course. Updated after you enrol, so it reflects where the work stands now. The 144-chapter course is included behind it, for the parts you want to go deeper on.
You're expected to lead AI adoption in drug discovery, but the options are opaque and the risks are high.

The situation this is built for

Every day, pressure mounts to adopt artificial intelligence in drug discovery. You're asked to evaluate platforms that promise faster target identification, generative chemistry, and predictive toxicology. But without a clear internal benchmark, it's impossible to assess whether these tools fit your data landscape, align with clinical development timelines, or comply with regulatory standards. You need a framework that separates capability from hype — one rooted in your organization's actual data infrastructure, cross-functional workflows, and decision rights.

Who this is for

Chief data officer at a mid-to-large pharmaceutical company, responsible for data strategy in R&D, overseeing data governance, AI readiness, and cross-functional alignment between computational biology, medicinal chemistry, and clinical development teams.

Who this is not for

This is not for data scientists seeking technical tutorials, nor for executives wanting high-level trends. It is not for vendors selling platforms or consultants offering generic frameworks.

What you walk away with

  • Define a defensible AI adoption strategy aligned with pipeline priorities
  • Evaluate internal readiness for AI integration in discovery workflows
  • Map data lineage across target identification, lead optimization, and preclinical development
  • Establish cross-functional decision criteria for AI pilot projects
  • Build stakeholder alignment between informatics, research, and regulatory affairs

How this maps to your situation

  • Assessing current state of AI readiness
  • Identifying high-leverage integration points
  • Building organizational alignment and governance
  • Planning sustainable, compliant adoption

Before vs. after

Before
Uncertain about AI's real impact, pressured to commit without a clear evaluation framework, dependent on external narratives.
After
Confident in your assessment of AI's fit, equipped with a tailored roadmap, aligned with stakeholders on next steps.

What's included with your purchase

  • 12 modules with 12 chapters each (144 chapters)
  • Downloadable templates and worked examples for every module
  • Hand-built implementation playbook delivered alongside course access
  • 30-day money-back guarantee

Delivery and format

  • Course and learning environment access provisioned within 24 hours of purchase
  • Hand-built implementation playbook delivered alongside course access

Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.

Time investment: Approximately 3 hours per module, designed for completion over 12 weeks with team engagement.

If nothing changes
Without a structured way to evaluate AI, organizations risk investing in tools that fail to integrate, produce irreproducible results, or create regulatory exposure — delaying discovery timelines and eroding stakeholder trust.

How this compares to the alternatives

Unlike vendor-led trainings or academic courses, this program focuses exclusively on internal decision-making, governance, and operational integration — not technology promotion or theoretical concepts.

Also included: the full course, for when you want the reasoning behind a finding (12 modules, 144 chapters)

Depth reference. The diagnostic and the templates stand on their own; this is what to read when you want the reasoning behind a finding.

Module 1. Defining the Scope of AI in Drug Discovery
Establish clarity on what AI can and cannot do within your organization’s discovery pipeline.
12 chapters in this module
  1. Understanding the role of AI in target identification
  2. Differentiating machine learning from traditional QSAR models
  3. Mapping AI applications to preclinical development stages
  4. Assessing feasibility of generative chemistry workflows
  5. Identifying high-impact opportunities in lead optimization
  6. Evaluating AI for de novo molecule design
  7. Recognizing limitations in predictive toxicology models
  8. Aligning AI capabilities with clinical trial endpoints
  9. Defining success metrics for AI-driven discovery
  10. Balancing innovation speed with regulatory compliance
  11. Documenting assumptions about AI performance claims
  12. Setting boundaries for pilot project scope
Module 2. Auditing Current Data Infrastructure
Evaluate whether your existing data systems can support AI integration.
12 chapters in this module
  1. Inventorying structured data across R&D databases
  2. Assessing quality of high-throughput screening results
  3. Evaluating metadata completeness for compound libraries
  4. Reviewing ELN integration with computational workflows
  5. Identifying gaps in biomolecular interaction records
  6. Validating assay data consistency across studies
  7. Checking version control for chemical structure files
  8. Auditing data lineage from source to analysis
  9. Measuring reproducibility of in silico predictions
  10. Assessing interoperability of pharmacokinetic datasets
  11. Documenting data access permissions and silos
  12. Prioritizing data remediation for AI readiness
Module 3. Assessing Organizational Readiness
Determine if your teams have the skills and structures to adopt AI effectively.
12 chapters in this module
  1. Evaluating computational biology team capacity
  2. Measuring data literacy among medicinal chemists
  3. Assessing informatics support for model deployment
  4. Reviewing cross-functional collaboration mechanisms
  5. Identifying change resistance in discovery groups
  6. Benchmarking AI experience in research leadership
  7. Evaluating training needs for model interpretation
  8. Assessing documentation standards for AI outputs
  9. Reviewing project management practices for AI pilots
  10. Measuring stakeholder trust in algorithmic recommendations
  11. Evaluating escalation paths for model failures
  12. Documenting decision rights for AI-based proposals
Module 4. Mapping Discovery Workflows to AI Use Cases
Connect specific stages of drug discovery to potential AI interventions.
12 chapters in this module
  1. Tracing data flow from target validation to lead selection
  2. Identifying bottlenecks in hit-to-lead progression
  3. Linking AI predictions to experimental validation plans
  4. Mapping generative models to synthesis feasibility
  5. Aligning virtual screening outputs with assay scheduling
  6. Integrating predictive ADMET into candidate prioritization
  7. Connecting pathway analysis to target tractability scores
  8. Using natural language processing for literature mining
  9. Incorporating patient-derived data into target selection
  10. Feeding clinical biomarker data back into discovery loops
  11. Synchronizing AI timelines with compound production
  12. Defining handoff criteria between computational and lab teams
Module 5. Establishing Data Governance for AI Models
Implement policies that ensure responsible and compliant use of AI in discovery.
12 chapters in this module
  1. Defining ownership of AI-generated molecules
  2. Setting standards for model input data provenance
  3. Creating audit trails for algorithmic decision-making
  4. Documenting assumptions in training data selection
  5. Ensuring compliance with compound registry rules
  6. Applying FAIR principles to AI training datasets
  7. Managing intellectual property in model outputs
  8. Reviewing data retention policies for AI runs
  9. Establishing review cycles for model performance
  10. Defining versioning for AI-predicted structures
  11. Enforcing access controls for sensitive predictions
  12. Integrating model documentation into regulatory submissions
Module 6. Evaluating Model Performance and Validation
Develop criteria to assess whether AI models deliver reliable and reproducible results.
12 chapters in this module
  1. Defining validation benchmarks for generative models
  2. Assessing reproducibility of in silico screening results
  3. Measuring concordance between predicted and observed activity
  4. Establishing baseline metrics for model accuracy
  5. Designing prospective validation experiments
  6. Evaluating model robustness across chemical space
  7. Tracking false positive rates in virtual screening
  8. Validating uncertainty estimates in property prediction
  9. Comparing AI output against historical success rates
  10. Assessing generalizability to novel target classes
  11. Reviewing statistical power of model evaluation sets
  12. Documenting model failure modes and edge cases
Module 7. Integrating AI Outputs into Experimental Design
Ensure AI predictions inform lab work without disrupting established protocols.
12 chapters in this module
  1. Translating AI rankings into assay prioritization
  2. Designing experiments to test AI-generated hypotheses
  3. Balancing exploration and exploitation in screening
  4. Incorporating model confidence into test planning
  5. Scheduling follow-up assays based on AI rankings
  6. Adjusting compound synthesis batches using predictions
  7. Using AI to optimize dose-response study design
  8. Feeding back experimental results to refine models
  9. Synchronizing AI updates with lab production cycles
  10. Creating feedback loops between wet and dry labs
  11. Documenting discrepancies between prediction and outcome
  12. Adjusting models based on experimental validation
Module 8. Aligning AI Strategy with Regulatory Pathways
Anticipate how AI use in discovery will impact future regulatory submissions.
12 chapters in this module
  1. Anticipating regulatory questions about AI-generated leads
  2. Documenting model development for regulatory review
  3. Ensuring traceability of AI-influenced decisions
  4. Preparing data packages for regulatory inspectors
  5. Aligning AI workflows with GLP compliance standards
  6. Mapping AI use to ICH guideline requirements
  7. Planning for audit readiness in AI-driven projects
  8. Including model provenance in investigational brochures
  9. Reviewing labeling implications of AI-designed molecules
  10. Engaging regulatory strategy teams early in AI pilots
  11. Tracking decisions influenced by black-box predictions
  12. Building regulatory justification for AI-based prioritization
Module 9. Building Cross-Functional Decision Frameworks
Create governance structures that enable timely, evidence-based decisions on AI adoption.
12 chapters in this module
  1. Designing discovery review boards for AI projects
  2. Setting thresholds for advancing AI-suggested candidates
  3. Establishing escalation paths for model disagreements
  4. Creating scorecards for AI project performance
  5. Defining go/no-go criteria for AI-driven programs
  6. Aligning portfolio strategy with AI capabilities
  7. Facilitating joint sessions between chemists and data scientists
  8. Documenting rationale for rejecting AI recommendations
  9. Incorporating AI metrics into project reviews
  10. Balancing speed against validation burden in decisions
  11. Measuring impact of AI on project timelines
  12. Reporting AI contribution to pipeline progression
Module 10. Managing Intellectual Property and Data Rights
Navigate ownership, patentability, and data sharing in AI-driven discovery.
12 chapters in this module
  1. Assessing patent eligibility of AI-generated compounds
  2. Documenting inventorship in AI-assisted discoveries
  3. Reviewing data licensing agreements for training sets
  4. Evaluating trade secret protection for model parameters
  5. Managing joint development agreements with partners
  6. Tracking prior art in generative chemistry outputs
  7. Establishing internal review for AI-based disclosures
  8. Assessing freedom to operate for novel scaffolds
  9. Creating data use agreements for external collaborations
  10. Defining data ownership in co-developed models
  11. Reviewing publication policies for AI-influenced work
  12. Planning for IP audits in AI-integrated pipelines
Module 11. Scaling AI Pilots to Production Workflows
Plan the transition from proof-of-concept to integrated AI operations.
12 chapters in this module
  1. Assessing computational resource needs for AI deployment
  2. Designing workflows for continuous model retraining
  3. Integrating AI outputs into electronic lab notebooks
  4. Standardizing input formats across discovery stages
  5. Creating monitoring dashboards for model performance
  6. Planning for model drift detection and correction
  7. Establishing support teams for AI system maintenance
  8. Scaling data pipelines to handle AI throughput
  9. Ensuring reproducibility across model versions
  10. Building redundancy into AI-dependent workflows
  11. Evaluating long-term storage needs for AI runs
  12. Developing decommissioning plans for outdated models
Module 12. Creating a Long-Term AI Adoption Roadmap
Develop a sustainable strategy for evolving AI capabilities in line with organizational goals.
12 chapters in this module
  1. Assessing maturity of internal AI capabilities
  2. Setting milestones for capability building
  3. Aligning AI investment with pipeline priorities
  4. Planning for talent development in computational sciences
  5. Evaluating need for dedicated AI research units
  6. Balancing internal development with external partnerships
  7. Creating feedback mechanisms for AI strategy review
  8. Updating data architecture to support future AI
  9. Measuring ROI of AI initiatives over time
  10. Adapting governance to evolving regulatory landscape
  11. Incorporating lessons from failed AI pilots
  12. Communicating AI strategy to board and investors

Frequently asked

Is this course technical?
No. It is strategic and operational, designed for leaders who must make decisions about AI adoption without becoming data scientists.
How is the course structured?
12 modules, each containing 12 chapters (144 chapters total).
Will this help me justify an AI investment to leadership?
Yes. You will build a defensible assessment grounded in your organization's data, capabilities, and pipeline priorities.
Does the course cover regulatory compliance?
Yes. Modules address GLP alignment, data provenance, and documentation needed for regulatory submissions.
Can I use this with my team?
Yes. The course and templates are designed for team implementation and cross-functional workshops.
What formats do the templates come in?
The implementation playbook downloads as PDF and editable XLSX. The course reads in your learning environment and exports to PDF for offline use. The files are yours to keep.
Can I share this with my team?
The licence is per person. Team pricing opens from three seats: reply to the order confirmation with TEAM and we will set it up.
How quickly can I start?
The diagnostic is one sitting and the templates work straight out of the kit. Account access takes up to 24 hours rather than being instant, because every order is checked and updated against the latest sources before it is delivered.
$199 one-time. Approximately 3 hours per module, designed for completion over 12 weeks with team engagement..

Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.

30-day money-back guarantee·Know your weakest area today·210 scored questions·Course included· Account access within 24 hours
30-day money-back guarantee, no questions asked.
Thousands of organisations have bought from The Art of Service since 2000.
!